https://www.selleckchem.com/pr....oducts/bms-986205.ht
This study examines polypharmacy and prescription drug use patterns in cancer survivors, a growing population at risk for cancer sequelae and side effects from treatment, which can arise months or even years following diagnosis. Survivors may experience greater medication burden than the general population, increasing concerns for polypharmacy and subsequent risks of drug interactions and non-adherence. Using the National Health and Nutrition Examination Survey (NHANES) data from 2003 to 2014, we examined the association between a ca
إعجاب
علق
شارك
